ATAGI recommendations on COVID-19 vaccine use in children under 5 years

ATAGI have now recommended COVID-19 vaccination for some children aged 6 months – 5 years. Eligible groups include those with severe immunocompromise, a disability with severe or complex health needs, or those with multiple/complex health conditions that increase the risk of severe COVID-19 disease.  

A paediatric formula of the Moderna COVID-19 vaccine has been approved by the TGA in this age group for children in the groups mentioned above. A primary two-dose schedule, 8 weeks apart is recommended, with the dose being 25mcg. Children in this age group with severe immunocompromise are recommended to complete a 3-dose primary schedule.  

ATAGI does not currently recommend COVID vaccination for children aged 6 months - 5 years who are not in the categories previously mentioned, based on a range of factors.  

Recommendations may change as alternative brands or variant COVID-19 vaccines become available in this age group, or if there are epidemiological changes such as new variants of concern that emerge.  

To read the recommendations in full please follow the link below.  

ATAGI recommendations on COVID-19 vaccine use in children aged 6 months to <5 years


Safety of COVID-19 vaccines in >200,000 Aussie kids: reassuring data from AusVaxSafety

New AusVaxSafety research which analysed 392,268 survey responses via AusVaxSafety’s national active safety surveillance system between July 2021 and May 2022, has found that Australian children aged 5-15 years report fewer side effects in the days following mRNA COVID-19 vaccination than those reported in clinical trials and published safety data.

Importantly, fever was reported low in the youngest age group, comparable to that seen following annual influenza vaccination. Additionally, there were also no self-reported cases of myocarditis and pericarditis identified in the study.

AusVaxSafety will commence surveillance in children aged 6 months to 5 years once COVID-19 vaccines become available in this age group.

To access the research in full, click on the link below. 

Safety of COVID-19 vaccines in >200,000 Aussie kids: reassuring data from
AusVaxSafety 
 


Flinders University Alumni publication featuring A/Prof Nigel Crawford: Providing the vital boost for us to fight COVID-19

MVEC’s Associate Professor Nigel Crawford was featured in the Flinders University College of Medicine and Public Health Alumni magazine regarding his significant contribution to Australia’s COVID-19 vaccine rollout. As the current chair of the Australian Technical Advisory Group for Immunisation (ATAGI), Nigel discusses his role in steering Australia’s uptake of COVID-19 vaccines, including effective communication and the ability to remain flexible when responding to and adapting vaccine advice for the general public. 

To read the full article, follow the link below.

Flinders University Alumni publication featuring A/Prof Nigel Crawford: Providing the vital boost for us to fight COVID-19 


Registrations now open for MVEC’s Immunisation Skills Workshop – Friday 25 November 2022

MVEC are pleased to announce that registrations for our Immunisation Skills Workshop taking place on Friday 25th November are now open.  

The full day interactive, face to face workshop is MVEC’s newest education opportunity designed to provide education and upskilling in the principles and processes of managing: 

  • effective vaccine communication 
  • error prevention and management 
  • anaphylaxis and acute stress responses. 

Participants will hear from immunisation experts and have the opportunity to engage in simulated scenarios. 

The workshop will account for 12 nursing CPD hours and up to 24 points of CPD for pharmacist immunisers (including preparation and reading time). 

Venue: The HELP Precinct, The Royal Children’s Hospital, 50 Flemington Road, Parkville
Time: 8:30am – 4:30pm
Cost: $290.00 (including catering) 

Register for the Immunisation Skills Workshop now via the link below!
MVEC Immunisation Skills Workshop 


Registrations opening soon for our next CVU mini August event

MVEC’s next Clinical Vaccinology Update (CVU) mini event on COVID-19: infection and vaccines in children aged 6 months and over will take place virtually in August, with the date to be announced shortly.  This CVU mini will provide an update on: 

  • COVID-19 vaccine recommendations for Australian children over 6 months 
  • The safety profile of COVID-19 vaccines in children 

The event program and link to register will be available shortly via our Events page or via the link below. 

CVU mini: August 2022 

 


New resource for adults added to the MVEC immunisation information hub for the general public

Immunisation throughout life is an important way to remain protected against vaccine preventable diseases, and not only protects the individual, but more vulnerable members of society.  

Our dedicated immunisation resource for the general public includes information on the HALO principle when considering immunisation for adults, Health, Age, Lifestyle and Occupation, as well as vaccine recommendations, answers to frequently asked questions and links to further resources. 

MVEC’s hub of up-to-date and reliable information aims to increase the public’s awareness and understanding of vaccine preventable diseases and promote the benefits of immunisation for people of all ages. 

If you are interested in collaborating with MVEC to develop immunisation resources, we’d love to hear from you! 

To access this new resource for seniors, please click on the link below.
MVEC’s Immunisation hub for the general public